Ad
related to: glaucoma gene therapy clinical trials in california state hospital surveyors
Search results
Results from the WOW.Com Content Network
A number of recent clinical trials have suggested that gene therapy could help treat diseases of the eye that cause vision loss. This Special Feature explores the current evidence and outstanding ...
Doheny and USC ended their relationship in 2012, and USC created a new entity called the USC Eye Institute for its department of ophthalmology. [16] In December 2013 the Doheny Eye Institute entered into an exclusive, long-term affiliation agreement with the University of California Los Angeles , [ 17 ] forming the "Doheny Eye Center UCLA".
Retinal gene therapy holds a promise in treating different forms of non-inherited and inherited blindness. In 2008, three independent research groups reported that patients with the rare genetic retinal disease Leber's congenital amaurosis had been successfully treated using gene therapy with adeno-associated virus (AAV).
Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need.
The first retinal gene therapy to be approved by the FDA was Voretigene neparvovec in 2017, which treats Leber's congenital amaurosis, a genetic disorder that can lead to blindness. These treatments also use subretinal injections of AAV vector and are therefore foundational to research in gene therapy for color blindness. [2] [3]
Translational Genomics Research Institute; California. Clear Labs; Genetic Information Research Institute; Joint Genome Institute (U.S. Department of Energy) Salk Institute for Biological Studies; Illinois. Carl R. Woese Institute for Genomic Biology (University of Illinois, Urbana-Champaign) Maine. The Jackson Laboratory; Maryland. Howard ...
"Gene Therapy Arrives". Scientific American This page was last edited on 10 November 2024, at 06:28 (UTC). Text is available under the Creative Commons Attribution ...
For premium support please call: 800-290-4726 more ways to reach us
Ad
related to: glaucoma gene therapy clinical trials in california state hospital surveyors